Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 13Insulin Resistance 3Hyperandrogenism 3Metabolic Syndrome 2Solid Tumors 1Primary Dysautonomias 1Overweight 1Observational Study 1Motor Activity 1Menstruation Disturbances 1Infertility 1Hirsutism 1Endometrial Neoplasms 1Depression 1Breast Neoplasms 1Bipolar Disorder 1Anxiety Disorders 1Advanced Malignancies 1

Interventions

Exercise 249Resistance Training 32Surveys and Questionnaires 22High-Intensity Interval Training 20Walking 15Diet 14Preoperative Exercise 13Methods 13Exercise Therapy 13Control Groups 12Standard of Care 11Nutritional Status 9Counseling 8Nutrition Assessment 7methyl hydroxyethyl cellulose 5Motivational Interviewing 5Fitness Trackers 5Diet Therapy 5Physical Therapy Modalities 4Nutritional Support 4Interviews as Topic 4Educational Status 4Cognitive Behavioral Therapy 4Behavior Therapy 4Wearable Electronic Devices 3Therapeutics 3Rehabilitation 3Palliative Care 3Metformin 3Exercise Test 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Motor Activity × Ethinyl Estradiol × Clear all
NCT00593294 2008-01-15

Oral Contraceptive and Cardiovascular Risk in PCOS

Federico II University

Phase 4 Completed
150 enrolled

Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡